Research study Program year 2025 Source: CMS Open Payments

Cemiplimab Survivorship Epidemiology (Case) Study

ClinicalTrials.gov NCT03836105

Research payments

$2,220,334

1,049 payments

Through program year 2025, $2,220,334 in research payments was reported against Cemiplimab Survivorship Epidemiology (Case) Study, across 1,049 payments, paid by Regeneron Pharmaceuticals, Inc..

Paid by: Regeneron Pharmaceuticals, Inc.
ClinicalTrials.gov: NCT03836105

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$204,258	81
2024	Research	$162,230	92
2023	Research	$438,407	165
2022	Research	$437,267	218
2021	Research	$381,384	242
2020	Research	$596,787	251

Breakdown

Who paid Research payments · program years 2020–2025

Regeneron Pharmaceuticals, Inc. $2,220,334 1,049 payments

Who received the money Research payments · program years 2020–2025

Institute For Medical Research INC Organisation paid for research $242,022 52 payments
Regents Of The Univ Of Ca-San Diego Organisation paid for research $158,918 32 payments
The University Of Texas Southwestern Medical Center Organisation paid for research $113,678 48 payments
Northwestern University Organisation paid for research $111,563 21 payments
Moffitt Cancer Center Teaching hospital · FL $97,943 59 payments
Biomedical Research Alliance Of New York LLC Organisation paid for research $97,501 63 payments
University Of Virginia Medical Cente Teaching hospital · VA $84,572 26 payments
University Of Vermont Medical Center Teaching hospital · VT $70,823 21 payments
Ut Md Anderson Cancer Center Teaching hospital · TX $66,126 11 payments
Regents Of The University Of Colorado Organisation paid for research $65,602 32 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.